000 01263 a2200337 4500
005 20250512084124.0
264 0 _c19851009
008 198510s 0 0 eng d
022 _a0031-6970
024 7 _a10.1007/BF00544361
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAbernethy, D R
245 0 0 _aImpairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_c1985
300 _a425-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aCaffeine
_xmetabolism
650 0 4 _aContraceptives, Oral
_xadverse effects
650 0 4 _aContraceptives, Oral, Hormonal
_xadverse effects
650 0 4 _aCytochrome P-450 Enzyme System
_xanalysis
650 0 4 _aDrug Interactions
650 0 4 _aEstrogens
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLiver
_xmetabolism
650 0 4 _aMetabolic Clearance Rate
_xdrug effects
700 1 _aTodd, E L
773 0 _tEuropean journal of clinical pharmacology
_gvol. 28
_gno. 4
_gp. 425-8
856 4 0 _uhttps://doi.org/10.1007/BF00544361
_zAvailable from publisher's website
999 _c4034932
_d4034932